The new breakthrough that could stop pancreatic cancer in its tracks

Scientists have uncovered a “target” for drug treatments that could potentially stop the spread of pancreatic cancer – which has one of the worst survival rates of all cancers.

Researchers from The Institute of Cancer Research in London studied pancreatic ductal adenocarcinoma (PDAC) – one of the most common and aggressive forms of the disease.

They discovered that blocking a protein, known as SPP1, stopped the spread of the cancer and increased survival times – opening the door to drug treatments targeting the protein. New Feature

In Short

Quick Stories. Same trusted journalism.

Pancreatic cancer is hard to treat and often diagnosed at such an advanced stage that seven in ten people receive no active treatment.

Almost 11,000 people are diagnosed with pancreatic cancer each year